Alcon
在场
Alcon 的所有者是 Novartis.
是其中之一......
- Forbes Global 2000 (#99);
- Fortune 500 Europe (#62);
- Global Fortune 500 (#263);
- Stoxx 600;
- Swiss market index;
- TOB Iconic 10,000.
Novartis 是一家在股票代码 NOVN (CH) 下上市的公司。
Novartis 在 38 个国家有直接业务。Novartis 拥有 73家子公司，其中包括 Advanced Accelerator Applications、Alcon 和 Alcon ANZ。
他们在：
涉及Novartis的并购和融资。
- Novartis has announced the acquisition of Chinook Therapeutics (公布2023八月14号).
- Novartis has announced the acquisition of DTx Pharma (公布2023七月18号).
- Novartis has announced the acquisition of Chinook Therapeutics (公布2023六月15号).
高管
查看带有其 51 名主要高管的组织结构图
Alcon 搜索最多的简介
高管在Alcon变化
- Terry Kim已作为Chief Medical Officer and Head of Global Medical Safety加入公司 (新闻发布的2024三月27号).
高管在Novartis变化
- Joerg Reinhardt, Chairman of the Board, 将于 20253月 退休 (新闻发布的2024四月25号).
创建提醒
跟踪 Alcon 的高管变动
医疗设备
Novartis 拥有 1,005 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- Precision Neuroscience 刚刚宣布为 102 筹款数百万美元。 (公布2024十二月18号).
- electroCore 已收购 NeuroMetrix (公布2024十二月18号).
- Anteris Technologies 刚刚宣布为 89 筹款数百万美元。 (公布2024十二月16号).
医疗设备 行业的其他推荐联系人
消息
Alcon 的最新新闻稿
- Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
- Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
- Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
- Alcon Debuts Latest Digital Innovations, SMARTCataract DX and NGENUITY 1.5, at ESCRS
- Alcon Announces New Cataract Surgery Outcomes Data, Hosts Robust Educational Program at ESCRS
- Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
- Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
- Alcon Completes Acquisition of BELKIN Vision, Expanding Glaucoma Portfolio with Direct Selective Laser Trabeculoplasty (DSLT) Device
- Alcon Announces Results of 2024 Annual General Meeting
- Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
- View more press releases Close
通过电子邮件
